找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Scleritis; Carlos Pavesio Book 2017 Springer International Publishing AG 2017 Complications.Immunosuppressive therapy.Infectious scleritis

[復(fù)制鏈接]
樓主: 方面
11#
發(fā)表于 2025-3-23 13:37:58 | 只看該作者
Complications and Their Management, some patients may decrease their vision. Keratitis in scleritis involves the adjacent peripheral cornea and may be present in about 13% of patients. Peripheral keratitis in scleritis includes peripheral corneal thinning, stromal keratitis, and, the most severe form, peripheral ulcerative keratitis.
12#
發(fā)表于 2025-3-23 14:01:43 | 只看該作者
13#
發(fā)表于 2025-3-23 19:33:17 | 只看該作者
Management with Steroids: Local and Systemic,eatment of ocular inflammatory conditions for decades. Upon ruling out infectious or masquerade conditions, anti-inflammatory medications and corticosteroids can then be used in the management of scleritis. There are various administration routes for corticosteroids, namely, topical, subconjunctival
14#
發(fā)表于 2025-3-24 02:12:40 | 只看該作者
15#
發(fā)表于 2025-3-24 05:01:47 | 只看該作者
Associated Systemic Diseases, than other rheumatic diseases. Less commonly associated conditions include seronegative spondyloarthropathies, polyarteritis nodosa sarcoidosis, cryoglobulinemia, and hypocomplementemic urticarial vasculitis. The most commonly associated infections with scleritis are herpes zoster and herpes simplex.
16#
發(fā)表于 2025-3-24 07:30:59 | 只看該作者
Management of Scleritis with Immunosuppressive Drugs and Biologic Agents,yclosporine, tacrolimus; and the alkylating agents, cyclophosphamide, chlorambucil) and biologic agents (TNF-α inhibitors, etanercept, infliximab, adalimumab; the IL-1 receptor antagonist, anakinra; the IL-2 receptor antagonist, daclizumab; and the anti-CD20/B-cell antibody, rituximab) will be discussed.
17#
發(fā)表于 2025-3-24 11:28:51 | 只看該作者
Book 2017damental features of the pathogenesis of scleral inflammation are first discussed as a basis for understanding the therapeutic strategies. Detailed descriptions are then provided of clinical manifestations, the complications that can arise during the course of the disease process, and the best way t
18#
發(fā)表于 2025-3-24 18:39:19 | 只看該作者
tal capabilities at LaRC and foster interaction with these facilities. (3) review current state-of-the-art and propose future directions for instability and transition research, (4) accelerate progress in elucidating basic understanding of transition phenomena and in transferring this knowledge into
19#
發(fā)表于 2025-3-24 20:34:49 | 只看該作者
20#
發(fā)表于 2025-3-25 03:03:00 | 只看該作者
Dinesh Visva Gunasekeran MBBS,Mi Fang Helen MBBS,Rupesh Agrawal FRCS, MD full three-dimensional triple-deck-lie interaction, f. The strongest nonlinear interactions are those of d,e,f since they alter the mean-flow profile substantially, i.e., by an 0(1) relative amount. All the types of nonlinear interaction however can result in the formation of focussed responses in
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 06:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
海晏县| 宜兰市| 綦江县| 河北区| 天峨县| 常德市| 厦门市| 广州市| 和林格尔县| 蛟河市| 镇沅| 皋兰县| 许昌县| 太仆寺旗| 抚顺市| 勐海县| 阳信县| 临西县| 汶川县| 怀仁县| 西畴县| 永安市| 天长市| 綦江县| 福贡县| 沧源| 洮南市| 峨边| 二连浩特市| 玛曲县| 淮安市| 白城市| 五寨县| 天镇县| 聊城市| 卓资县| 松滋市| 全州县| 岑巩县| 台东市| 襄汾县|